Higher Risk of Adverse Outcomes for Births to Young CA Survivors

Share this content:
Higher Risk of Adverse Outcomes for Births to Young CA Survivors
Higher Risk of Adverse Outcomes for Births to Young CA Survivors

FRIDAY, March 24, 2017 (HealthDay News) -- The risk of preterm birth and low birth weight is increased for live births for adolescent and young adult (AYA) cancer survivors (diagnosed at ages 15 to 39), according to a study published online March 23 in JAMA Oncology.

Chelsea Anderson, M.P.H., from the University of North Carolina at Chapel Hill, and colleagues identified female AYA cancer survivors diagnosed from January 2000 to December 2014 from the North Carolina Central Cancer Registry. The authors linked records to statewide birth certificate files to identify postdiagnosis live births to AYA survivors (2,598 births). These were matched with a comparison cohort of 12,990 births to women without a recorded cancer diagnosis.

The researchers found that births to AYA cancer survivors had a significantly increased prevalence of preterm birth, low birth weight, and cesarean delivery relative to the comparison cohort (prevalence ratios, 1.52, 1.59, and 1.08, respectively). The higher prevalence of these outcomes was mainly seen for births to women diagnosed during pregnancy. Treatment with chemotherapy and diagnosis of breast cancer, non-Hodgkin's lymphoma, or gynecologic cancers were associated with preterm birth and low birth weight.

"Live births to AYA cancer survivors may have an increased risk of preterm birth and low birth weight, suggesting that additional surveillance of pregnancies in this population is warranted," the authors write. "Our findings may inform the reproductive counseling of female AYA cancer survivors."

Abstract/Full Text

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »


Sign up for myCME e-newsletters


Drug Lookup

Browse drugs by: BrandGenericDisease

Trending Activities

All Professions

More in Home

Higher Fish Intake Appears to Reduce RA Symptoms

Higher Fish Intake Appears to Reduce RA Symptoms

Researchers suggest most varieties of fish may play a role in controlling symptoms

Longer Survival for Midostaurin  Chemotherapy in AML With FLT3

Longer Survival for Midostaurin + Chemotherapy in AML ...

Prolonged overall, event-free survival for patients with acute myeloid leukemia, FLT3 mutation

HIV Testing Inadequate in Young Men Who Have Sex With Men

HIV Testing Inadequate in Young Men Who Have ...

Only 28 percent of young MSM have HIV testing, though they account for 83 percent of new diagnoses

is free, fast, and customized just for you!

Already a member?

Sign In Now »